Predictive genomic markers of response to VEGF targeted therapy (TT) in metastatic renal cell carcinoma (mRCC): Role of VHL and TP53 mutation, and FLT1 germline variant
Predictive genomic markers of response to VEGF targeted therapy (TT) in metastatic renal cell...
Read More